HUDSON, N.H., Oct. 18 /PRNewswire/ -- The New Hampshire Bio/Medical Council held its 2nd Annual Awards Dinner on October 14, 2010 at the Wentworth-By-The-Sea Country Club in Rye, NH. During the evening, the Bio/Medical Council awarded Atrium Medical Corporation of Hudson, NH the NH Bio/Medical Council Business of the Year Award. In attendance to accept the award were Ted Karwoski, Chief Operating Officer and Steve Vail, Group VP of Global Marketing.
The dinner also honored New Hampshire's senator, Judd Gregg and his long term support of the life sciences industry by establishing the Judd Gregg New Hampshire Bio/Medical Internship Program. This program is designed to provide summer internships to students or recent graduates who are considering careers in the life sciences industry. The number of interns will vary from year to year depending on demand and funding. The Bio/Medical sector is a viable and growing sector of New Hampshire businesses and with the Internship Program, the Council hopes to keep talented graduates here in New Hampshire.
The NH Bio/Medical Council, along with the efforts of Atrium Medical Corporation, strives to promote economic development in New Hampshire with long term goals in education, business development, job creation and retention. Established in 1999, the Council has worked steadily to establish a strong identity for the industry in New Hampshire and to network the academic, industry and government participants into a cohesive whole. In 2003, the Council began work to establish three consortiums for human resources, service providers and purchasing to support companies and affiliates in our industry.
Atrium is honored to be recognized by this organization and to receive this award.
Atrium's vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has brought a number of breakthrough advances in several diversified healthcare markets including interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and hernia repair. Maintaining a commitment to the latest ISO13485 Quality Standards, late breaking advancements in manufacturing and automation, cell biology and biomaterial research, Atrium continues to excel in those healthcare segments that require more advanced surgical intervention for life sustaining patient care. For more information please call Atrium's Marketing Communications Dept. at 1-800-370-7899 or visit Atrium's website at www.atriummed.com.
SOURCE Atrium Medical Corporation